Combination of the PAM4 and CA19-9 biomarkers to improve the detection of pancreatic adenocarcinoma.

被引：0
|
作者：
Gold, David V.
Gaedcke, Jochen
Ghadimi, B. Michael
Goggins, Michael
Hruban, Ralph H.
Liu, Mengling
Newsome, Guy
Goldenberg, David M.
机构：
[1] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA
[2] Univ Goettingen, Univ Med Ctr, Gottingen, Germany
[3] Johns Hopkins Med Inst, Baltimore, MD USA
[4] New York Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Halm, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5610 - 5610
  • [42] Serum CA19-9 determination in the management of pancreatic cancer
    vandenBosch, RP
    vanEijck, CHJ
    Mulder, PGH
    Jeekel, J
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 710 - 713
  • [43] Glycans Related to the CA19-9 Antigen Are Biomarkers of Pancreatic Cancer and Provide Added Value for Diagnostics
    Hsueh, Peter
    Barnett, Daniel
    Liu, Ying
    Partyka, Katie
    Tang, Huiyuan
    Kletter, Doron
    Huang, Ying
    Drake, Richard
    Brand, Randall E.
    Haab, Brian B.
    GLYCOBIOLOGY, 2016, 26 (12) : 1450 - 1451
  • [44] CA19-9 as a Prognostic Biomarker in Pancreatic Neuroendocrine Tumors
    Luo, G.
    Guo, M.
    Liu, Z.
    Liu, C.
    Cheng, H.
    Lu, Y.
    Jin, K.
    Zhang, B.
    Liu, L.
    Long, J.
    Xu, J.
    Ni, Q.
    Chen, J.
    Yu, X.
    NEUROENDOCRINOLOGY, 2016, 103 : 49 - 49
  • [45] CA19-9 as a Predictor of Resectability in Patients with Pancreatic Cancer
    He, Z.
    Lu, H.
    Hu, W.
    Tian, B.
    Zhang, Z.
    PANCREAS, 2011, 40 (08) : 1326 - 1326
  • [46] THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement
    Udgata, Shirsa
    Takenaka, Naomi
    Bamlet, William R.
    Oberg, Ann L.
    Yee, Stephanie S.
    Carpenter, Erica L.
    Herman, Daniel
    Kim, Jungsun
    Petersen, Gloria M.
    Zaret, Kenneth S.
    CANCER PREVENTION RESEARCH, 2021, 14 (02) : 223 - 231
  • [47] Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer
    Zhang, Jiayu
    Wang, Yue
    Zhao, Tiancheng
    Li, Yezhou
    Tian, Leilei
    Zhao, Jinming
    Zhang, Jingxin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [48] Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer
    Reitz, Daniel
    Gerger, Armin
    Seidel, Julia
    Kornprat, Peter
    Samonigg, Hellmut
    Stotz, Michael
    Szkandera, Joanna
    Pichler, Martin
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (06) : 427 - 433
  • [49] Circulating natural antibodies against 3′-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinoma
    Yamada, Keita
    Higashi, Kiyoshi
    Nagahori, Hirohisa
    Saito, Koichi
    CANCER BIOMARKERS, 2020, 27 (01) : 121 - 128
  • [50] Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer
    Jiayu Zhang
    Yue Wang
    Tiancheng Zhao
    Yezhou Li
    Leilei Tian
    Jinming Zhao
    Jingxin Zhang
    World Journal of Surgical Oncology, 18
12345